The pharmaceutical company, which has developed a vaccine for the corona virus, is working to adapt it to the new strain.
The battle against the mutations:
Modern Company announced today (Monday) that it is working to improve the vaccine it produces so that it will be effective against the South African strain of the corona virus.
Corona Commissioner Prof. Ash: "This may not be the last closure" // Photo: GPO
According to tests conducted by the company in recent weeks, it estimates that the vaccine it produces is effective against the British mutation, as well as against the South African mutation, but the effectiveness of the vaccine against the latter strain is less.
According to the test results, although the antibodies that the vaccine produces are less adapted to the infectious strain, they are still sufficient to bring about the vaccine against the disease.
The company stated that the concern is that the effect of the vaccine against the South African strain will be shorter.
The company explained that they are taking this course "out of caution, and taking advantage of the flexibility of our vaccination method", adding: "I am progressing in developing a version of the vaccine that will work better against the strain discovered in South Africa. Also against future varieties that have not yet been discovered. "
